Small Caps Dashboard
 

LBT INNOVATIONS


Sector: Biotech

Industry:

Adelaide based LBT has developed an automated machine that utilises artificial intelligence for use in pathology laboratories. Its Automated Plate Assessment System (APAS) platform technology automates culture-plate screening and interpretation, speeding up the process by at least three times compared to manual reading. The technology was developed by LBT in collaboration with the University of Adelaide’s Australian Institute of Machine Learning (AIML).

See our recomndations.
Unlock

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec porttitor semper molestie. Ut eleifend, erat eu pulvinar iaculis, odio nunc venenatis tellus, ut placerat lorem purus sed tellus. Duis ut leo vitae massa facilisis dictum sed a dui. Proin quis pulvinar purus, vestibulum lobortis justo.

 
  • Radar Rating Unlock
  • Market Cap ($m)* 29.4
  • Dividend Yield (%)* 0
  • NET CASH ($M) 8
  • * Data as of 30 July 2021

Latest Research Summary

LBT INNOVATIONS: RESEARCH TIP UPDATES - MAY 2019
22 May, 2019

Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Maecenas ut ex et est semper fringilla. Nam et lectus augue. Integer non consectetur ligula. Maecenas tortor metus, molestie at aliquam sit amet, feugiat sed ipsum. Donec vehicula mi ac neque tempor dignissim.

Unlock to view the latest research

Previous Research

Research Date Radar Rating  
LBT INNOVATIONS: RESEARCH TIP UPDATES - MAY 2019 22 May, 2019 aa0db7ae View Research
LBT INNOVATIONS: MED-TECH APRIL 2018 12 Apr, 2018 df7c0b34 View Research
LBT INNOVATIONS: RESEARCH TIP UPDATES - DECEMBER 2017 07 Dec, 2017 ed47c38b View Research
LBT INNOVATIONS: RESEARCH TIP UPDATE - SEPTEMBER 2017 28 Sep, 2017 88aa75dc View Research
LBT INNOVATIONS: RESEARCH TIP - JULY 2017 13 Jul, 2017 364f3b9e View Research